AbbVie to Present at Cowen and Company 33rd Annual Health Care Conference

Wed Feb 20, 2013 9:15am EST

* Reuters is not responsible for the content in this press release.

For best results when printing this announcement, please click on the link
below:

http://pdf.reuters.com/pdfnews/pdfnews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20130220:nPnCG61796


NORTH CHICAGO, Ill.,  Feb. 20, 2013  /PRNewswire/ -- AbbVie (NYSE: ABBV) will
present at the Cowen and Company 33rd  Annual Health Care Conference on 
Wednesday, March 6, 2013.   Bill Chase, executive vice president and chief
financial officer, will make a formal presentation on the company at  7:40 a.m.
Central time.

A live audio webcast of the presentation will be accessible through AbbVie's
Investor Relations Web site at  www.abbvieinvestor.com.  An archived edition of
the presentation will be available later that day.  



About AbbVie
AbbVie is a global, research-based biopharmaceutical company formed in 2013
following separation from Abbott. With its 125-year history, the company's
mission is to use its expertise, dedicated people and unique approach to
innovation to develop and market advanced therapies that address some of the
world's most complex and serious diseases. In 2013, AbbVie employs approximately
21,000 people worldwide and markets medicines in more than 170 countries. For
further information on the company and its people, portfolio and commitments,
please visit  www.abbvie.com. Follow  @abbvie  on Twitter or view careers on our
 Facebook or  LinkedIn  page.

SOURCE  AbbVie


Adelle Infante, Media, +1-847-938-8745; Liz Shea, Investors, +1-847-935-2211

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.